Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Global Device Approvals, Weekly Snapshot: Roche’s Breast-Cancer Companion Diagnostic; Nemara’s Eye-Dropper

Executive Summary

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week, US FDA approved Roche’s Ventana PD-L1 assay as the first companion diagnostic to aid in identifying triple-negative breast cancer, and Nemera announced that its Novelia Cosopt iMulti eye-dropper will soon be available in 29 European countries.

Topics

Related Companies

UsernamePublicRestriction

Register

MT124771

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel